McGuire Investment Group’s Biogen BIIB Stock Holding History

McGuire Investment Group’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,466	Closed	-$391K	–	116
2022 Q3	$391K	Hold	1,466	–	–	0.09%	81
2022 Q2	$299K	Hold	1,466	–	–	0.06%	95
2022 Q1	$309K	Hold	1,466	–	–	0.06%	96
2021 Q4	$352K	Sell	1,466 -179	-11%	-$46K	0.06%	92
2021 Q3	$466K	Sell	1,645 -25	-1%	-$8.19K	0.09%	83
2021 Q2	$578K	Sell	1,670 -1,659	-50%	-$503K	0.11%	76
2021 Q1	$931K	Sell	3,329 -15	-0.4%	-$4.04K	0.2%	57
2020 Q4	$819K	Sell	3,344 -352	-10%	-$90.8K	0.2%	55
2020 Q3	$1.05M	Sell	3,696 -60	-2%	-$16.7K	0.31%	49
2020 Q2	$1M	Hold	3,756	–	–	0.35%	44
2020 Q1	$1.19M	Hold	3,756	–	–	0.49%	40
2019 Q4	$1.11M	Hold	3,756	–	–	0.33%	49
2019 Q3	$875K	Sell	3,756 -20	-0.5%	-$4.66K	0.29%	54
2019 Q2	$883K	Sell	3,776 -216	-5%	-$49.9K	0.28%	56
2019 Q1	$944K	Hold	3,992	–	–	0.31%	54
2018 Q4	$1.2M	Hold	3,992	–	–	0.45%	51
2018 Q3	$1.41M	Buy	+3,992	New	+$1.37M	0.47%	50

Other funds holding BIIB

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

McGuire Investment Group's BIIB Position: Q4 2022 in Review

McGuire Investment Group sold out of Biogen (BIIB) in Q4 2022, closing a stake of 1,466 shares — an estimated $391K sold.

McGuire Investment Group first reported a position in BIIB in Q3 2018 and held it in 17 quarters. The position peaked at $1.41M in Q3 2018. 1,031 funds tracked by Wall St. Rank hold BIIB as of Q4 2022.

McGuire Investment Group reported no remaining Biogen position as of Q4 2022 after selling out during the quarter.
McGuire Investment Group sold 1,466 Biogen shares in Q4 2022, an estimated $391K.
McGuire Investment Group first reported a position in Biogen in Q3 2018 and held it in 17 quarters.
McGuire Investment Group's Biogen position peaked at $1.41M in Q3 2018.
1,031 funds tracked by Wall St. Rank held Biogen as of Q4 2022.

Based on McGuire Investment Group's 13F filing for Q4 2022, filed 10 Jan 2023.